Skip to content

A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder

A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder - A clinical study to evaluate the anti-obesity effect of capsules containing noni fruit powder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030607
Enrollment
6
Registered
2019-02-17
Start date
2018-01-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intake of capsules containing noni fruit powder for 4 weeks

Sponsors

Soiken Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subject whose age of 20 years or more and less than 55 years at informed consent 2) Subject whose BMI is 25 kg/m2 or more and less than 30 kg/m2 3) Subject who weighs less than 88 kg 4) Subject having a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent

Exclusion criteria

Exclusion criteria: 1) Subject who has a mental disease such as depression, schizophrenia, epilepsy or bulimia nervosa 2) Subject who has allergic disease, cardiovascular, respiratory, thyroid gland malfunction, diabetes, heart disease, brain disease, gout or sleep disorder 3) Subject who takes regularly medicinal drugs or pharmaceuticals having an effect on the weight 4) Subject who has the possibility of developing allergic symptoms by the test food (noni allergy) 5) Subject who has a snacking habit 6) Female subject who is pregnant or may be pregnant 7) Female subject who is in lactating 8) Subject who has blood sample of 200 ml or more within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 9) Subject who participated in other clinical trials within the past 4 months or currently participates in other clinical trials or plans to participate in other clinical trials during the examination period 10) Subject deemed unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
Body weight, BMI

Secondary

MeasureTime frame
Waist circumference, Visceral fat area, Total fat percentage, Total fat area

Countries

Japan

Contacts

Public ContactTomohiro Sugino

Soiken Inc. R&D Division

sugino@soiken.com06-6871-8888

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026